Assessment of negative control outcome
death
SARS-COV-2 INFECTION, CARDIOVASCULAR DISEASE, MYOCARDIAL INFARCTION, STROKE, CVD, HEART FAILURE
We used two negative control outcomes (i.e., SARS-CoV-2 infection occurred over the 14 days after receiving the first dose of the COVID-19 vaccine and death from cardiovascular disease [CVD] defined as a death within 30 days before or after documentation of myocardial infarction, stroke or heart failure) to evaluate for potential residual confounding [